CALQUENCE vs EVEROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. CALQUENCE and EVEROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CALQUENCE	EVEROLIMUS
Rating	70/100	72/100
Pharmacy pays	—	~$219.28 /30
Type	RX	RX
Active ingredient	ACALABRUTINIB	EVEROLIMUS
Manufacturer	Astrazeneca	Biocon Pharma
Dosage forms	Capsule, Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Half-life	—	about 30 hours (mean terminal elimination half-life)
Treats	Mantle-Cell Lymphoma	—

calquence everolimus

Rating

70/100

72/100

Pharmacy pays

—

~$219.28 /30

Type

Active ingredient

ACALABRUTINIB

EVEROLIMUS

Manufacturer

Astrazeneca

Biocon Pharma

Dosage forms

Capsule, Tablet

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Half-life

—

about 30 hours (mean terminal elimination half-life)

Treats

Mantle-Cell Lymphoma

—

Frequently asked questions

Which is better-rated, Calquence or Everolimus?

By our independent rating, Everolimus scores higher — 3.6 vs 3.5 out of 5 for Calquence. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Calquence and Everolimus?

Calquence contains Acalabrutinib, while Everolimus contains Everolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.